Skip to main content

Animations

MJFF Publications

3601 - 3610 of 6422 Results
Title
Year
  • Year
  • 2018
  • 2022
  • 2022
  • 2022
  • 2012
  • 2017
  • 2025
  • 2020
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress
    Journal Name: Redox Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Transparent Exploration of Machine Learning for Biomarker Discovery from Proteomics and Omics Data
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.2c00473
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29171
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Systematic Functional Analysis of PINK1 and PRKN Coding Variants
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11152426
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020
    Citation Count: 139
  • Summary Details
    OPEN
    Title: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2025.02.014
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Cortical disinhibition in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa274
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease
    Journal Name: Advanced Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/adma.202304654
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-023-00346-0
    Citation Count: 26
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.